It belongs to a new generation of weight management medicines known as triple hormone receptor agonists meaning it acts on three different metabolic pathways simultaneously rather than one or two
A Conceptual Model of Food Cue Reactivity - PMC - PubMed Central, accessed April 22, 2025, GLP1 receptor agonists for the treatment of obesity: Role as a promising approach, accessed April 22, 2025, GLP-1 and the Neurobiology of Eating Control: Recent Advances - Oxford Academic, accessed April 22, 2025, pmc.ncbi.nlm.nih.gov, accessed April 22, 2025, Taking a GLP-1
b , Generic structure of the flavonoid skeleton, including numbering and ring nomenclature
These interactions can make semaglutide less effective or make its side effects worse